>

Vertex Technical Analysis

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

As of the 28th of February Vertex Pharmaceuticals has Risk Adjusted Performance of 0.0393, Coefficient Of Variation of 3076.82 and Semi Deviation of 1.43. In relation to Fundamental Indicators, Macroaxis technical analysis interface makes it possible for you to check existing technical drivers of Vertex Pharmaceuticals as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past prices and volume data or the prices will eventually revert. We found nineteen technical drivers for Vertex Pharmaceuticals Incorpor, which can be compared to its competition. Please validate Vertex Pharmaceuticals Value At Risk as well as the relationship between Semi Variance and Kurtosis to decide if Vertex Pharmaceuticals is priced more or less accurately providing market reflects its prevalent price of 222.74 per share. Given that Vertex Pharmaceuticals has Jensen Alpha of 0.0922, we advise you double-check Vertex Pharmaceuticals Incorpor current market performance to make sure the company can sustain itself at future point.
Equity
Refresh
Target PriceAdvice# of Analysts
261.81Buy16Odds
Vertex Pharmaceuticals Incorpor current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Vertex Pharmaceuticals Analyst Advice  

Vertex Pharmaceuticals Technical Analysis

Indicator
Time Period
  Portfolio Suggestion    
  
Execute Indicator
 
The output start index for this execution was seven with a total number of output elements of fifty-four. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vertex Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

Vertex Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Vertex Pharmaceuticals Incorpor. You can use it to identify possible trend reversals for Vertex Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vertex Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Vertex Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Vertex Pharmaceuticals Incorpor applied against its price change over selected period. The best fit line has a slop of   0.40  which means Vertex Pharmaceuticals Incorpor will continue generating value for investors. It has 122 observation points and a regression sum of squares at 5930.59, which is the sum of squared deviations for the predicted Vertex Pharmaceuticals price change compared to its average price change.

Vertex Pharmaceuticals February 28, 2020 Technical Indicators

Vertex Pharmaceuticals February 28, 2020 Daily Price Condition

Also please take a look at World Market Map. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Company logos by clearbit